Presentation TCT 2015

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? The Mechanism and Data Support Cangrelor!

Presenter: Harvey D. White

October 11, 2015

REGISTER for free or LOG IN to view this content

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? The Mechanism and Data Support Cangrelor!

Presentation

TCT 2015

Up Next

Presentation TCT 2015

Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and Vorapaxar Should Be Considered!

Presenter: Ori Ben-Yehuda

October 11, 2015

More slides +

Presentation TCT 2015

My AUC Scorecard Doesnt Look Good: What Should I Do?

Presenter: Ralph G. Brindis

October 11, 2015

Presentation TCT 2015

Hybrid Repair of a Complex Thoracoabdominal Aneurysm

Presenter: Sergey A. Abugov

October 11, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.